Posted by Michael David on June 8, 2013
Oregon Urology Institute
2400 Hartman Lane
Springfield, OR 97477
| Prostate Cancer – Medivation | |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Investigator) Primary Purpose: Treatment |
| Official Title: | A Multicenter Phase 2, Randomized, Double-Blind, Efficacy and Safety Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer Who Have Failed Primary Androgen Deprivation TherapyFor more information on this study visitclinicaltrials.gov |
| Prostate Cancer – PRIME | |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Prospective |
| Official Title: | Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-TFor more information on this study visit clinicaltrials.gov |
Active Trials
| Prostate Cancer – Dendreon PROCEED | |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate CancerFor More information on this study visitclinicaltrials.gov |
Source: Oregon Urology Institue: Clinical Trials
Leave a Comment